NIH-funded research R01 grant

Harnessing CAR T cells to unravel aging hallmarks in people with diabetes and heart disease

Official title: Harnessing CAR T cells to deconstruct the interconnectivity among hallmarks of aging

Funded at Cold Spring Harbor Laboratory · NIH-11330331 · Data updated 2026-11-12

Researchers are testing a CAR T cell approach to target aging-related cell states that may influence heart disease and diabetes in adults.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCold Spring Harbor Laboratory
NIH-funded
Lab location1 site (Cold Spring Harbor, United States)
Project startSeptember 15, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$516,478
NIH project number5R01AG082800-04
Project IDNIH-11330331 on NIH RePORTER

Who could benefit from this research

Could help

Adults with or at risk for adult-onset diabetes mellitus and atherosclerotic cardiovascular disease who could contribute biological samples or be considered for future translational trials.

Less likely to help

The study is focused on understanding aging biology and may not directly benefit individuals who do not have or are not at risk for these conditions.

What this research studies

This project uses specially designed CAR-T cells to remove aging-related cells in the body, aiming to uncover how aging hallmarks interact and drive conditions like adult-onset diabetes and atherosclerotic cardiovascular disease. By focusing on human-relevant pathways and leveraging prior proof-of-concept work, the study seeks to understand whether eliminating senescent cells can improve tissue function and lessen disease progression. The team plans to translate cellular findings into insights about potential treatments, using a combination of molecular, cellular, and animal model data to map connections among aging processes. Participation would help researchers learn how aging biology intersects with cardiovascular and metabolic diseases and what this could mean for future therapies.

Why it matters

Potential benefit: If successful, this research could point to new ways to treat or prevent aging-related heart and metabolic diseases by targeting senescent cells.

How similar studies have gone: Prior work showed that CAR T cells can target cellular senescence markers, supporting potential efficacy in aging-related contexts.

Where this research is happening

  • Cold Spring Harbor Laboratory
    Cold Spring Harbor, United States
    Active

Researchers

  • Principal investigator: Amor Vegas, Corina — Cold Spring Harbor Laboratory
  • Study coordinator: Amor Vegas, Corina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.